Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_45569 | 10 | 0.20 | Mlig455_050997 | Neo: - Age: - |
NPFFR2 | Mlig455_050997 {REF} {Length: 1679} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=95.0]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=74.7, Expect=9e-14]; ENSG00000102239, BRS3, bombesin receptor subtype 3, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000031130, Brs3, bombesin-like receptor 3, [Score=72.0, Expect=4e-13]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=69.3, Expect=2e-12]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=68.6, Expect=5e-12]; ENSMUSG00000031364, Grpr, gastrin releasing peptide receptor, [Score=68.6, Expect=4e-12]} {Dmel: FBgn0035610, Lkr, Leucokinin receptor, [Score=84.7, Expect=3e-17]} {Celegans: WBGene00006576, tkr-1, Probable G-protein coupled receptor tkr-1, [Score=65.9, Expect=2e-11]} {Smed: dd_Smed_v6_15625_0_1, dd_Smed_v6_15625_0_1, [Score=76.6, Expect=6e-15]} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 0.008 | 0.663 | 0.99994 | 1.00000 | |
RegionR2 | 1.875 | 0.663 | 0.99968 | 1.00000 | |
RegionR3 | -0.467 | 0.663 | 0.99998 | 1.00000 | |
RegionR4 | 0.21 | 0.663 | 0.99986 | 1.00000 | |
RegionR5 | -0.245 | 0.663 | 1.00000 | 1.00000 | |
RegionR6 | -0.752 | 0.663 | 0.99997 | 1.00000 | |
RegionR7 | -0.611 | 0.663 | 0.99994 | 1.00000 | |
RegionR8 | -0.019 | 0.663 | 0.99993 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -1.146 | 0.663 | 0.99995 | 1.00000 | |
RegenerationR2 | 0.945 | 0.663 | 0.94482 | 1.00000 | |
RegenerationR3 | -1.13 | 0.663 | 0.99992 | 1.00000 | |
RegenerationR4 | -1.151 | 0.663 | 0.99993 | 1.00000 | |
RegenerationR5 | -0.857 | 0.663 | 0.99992 | 1.00000 | |
RegenerationR6 | 1.653 | 0.663 | 1.00000 | 1.00000 | |
RegenerationBL | -0.983 | 0.663 | 0.99996 | 1.00000 | |
RegenerationTP | -0.761 | 0.663 | 0.99994 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_45569 | 10 | 0.2 | Mlig455_050997 | Neo: - Age: - |
NPFFR2 | 3 | - | - | 1.000 | 1.000 | 1.000 | - | Mlig455_050997 {REF} {Length: 1679} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=95.0]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=74.7, Expect=9e-14]; ENSG00000102239, BRS3, bombesin receptor subtype 3, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000031130, Brs3, bombesin-like receptor 3, [Score=72.0, Expect=4e-13]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=69.3, Expect=2e-12]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=68.6, Expect=5e-12]; ENSMUSG00000031364, Grpr, gastrin releasing peptide receptor, [Score=68.6, Expect=4e-12]} {Dmel: FBgn0035610, Lkr, Leucokinin receptor, [Score=84.7, Expect=3e-17]} {Celegans: WBGene00006576, tkr-1, Probable G-protein coupled receptor tkr-1, [Score=65.9, Expect=2e-11]} {Smed: dd_Smed_v6_15625_0_1, dd_Smed_v6_15625_0_1, [Score=76.6, Expect=6e-15]} |
2. | MligTC455_22323 | 68 | 1.42 | Mlig455_000713, Mlig455_000766 | Neo: - Age: - |
HCN4 | 2.796 | - | - | 0.957 | 0.953 | 0.886 | - | Mlig455_000713 {REF} {Length: 3555} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.6]; Cyclic nucleotide-binding domain [PF00027.31, score=70.8]; Ion transport protein [PF00520.33, score=62.7]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=581, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=568, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=579, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=563, Expect=0.0]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [RH, Score=512, Expect=1e-161]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=859, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} Mlig455_000766 {REF} {Length: 4037} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.5]; Cyclic nucleotide-binding domain [PF00027.31, score=70.7]; Ion transport protein [PF00520.33, score=62.6]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=566, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=553, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=564, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=548, Expect=3e-180]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [Score=502, Expect=4e-166]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=844, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} |
3. | MligTC455_14898 | 41 | 0.86 | Mlig455_011988 | Neo: - Age: - |
2.705 | - | - | 0.745 | 0.998 | 0.962 | - | Mlig455_011988 {REF} {Length: 858} {Pfam: Lectin C-type domain [PF00059.23, score=28.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
4. | MligTC455_37058 | 19 | 0.4 | Mlig455_061075 | Neo: - Age: - |
2.696 | - | - | 0.868 | 0.878 | 0.950 | - | Mlig455_061075 {REF} {Length: 4598} {Pfam: IQ calmodulin-binding motif [PF00612.29, score=31.8]} {RNA1509_56135} {RNA1310_6435} {RNA815_17633} | |
5. | MligTC455_15229 | 6 | 0.12 | Mlig455_032752 | Neo: - Age: - |
2.695 | - | - | 0.845 | 0.888 | 0.962 | - | Mlig455_032752 {REF} {Length: 1841} {Pfam: F5/8 type C domain [PF00754.27, score=51.0]; PAN-like domain [PF08277.14, score=26.2]} {Smed: dd_Smed_v6_1477_1_1, dd_Smed_v6_1477_1_1, [RH, Score=51.2, Expect=6e-08]} {RNA1509_36923} {RNA1310_46041} {RNA815_10591.1} | |
6. | MligTC455_53468 | 14 | 0.28 | Mlig455_070377 | Neo: - Age: - |
2.673 | - | - | 0.973 | 0.923 | 0.777 | - | Mlig455_070377 {REF} {Length: 2927} {Pfam: Glycine rich protein [PF12810.9, score=23.6]} {RNA1509_10020} {RNA1310_33363.2} {RNA815_25152} | |
7. | MligTC455_19578 | 23 | 0.47 | Mlig455_018093, Mlig455_059526 | Neo: - Age: - |
2.668 | - | - | 0.984 | 0.939 | 0.745 | - | Mlig455_018093 {REF} {Length: 2450} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=99.2]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=72.4, Expect=4e-13]} {RNA1310_65251} Mlig455_059526 {REF} {Length: 2621} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=101.4]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=74.7, Expect=8e-14]} {RNA1310_65251} |
|
8. | MligTC455_34987 | 27 | 0.56 | Mlig455_031823, Mlig455_047624, Mlig455_047675 | Neo: - Age: - |
KREMEN2 | 2.655 | - | - | 0.820 | 0.881 | 0.954 | - | Mlig455_031823 {REF} {Length: 873} {Pfam: WSC domain [PF01822.21, score=52.7]; PAN domain [PF00024.28, score=21.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.4, Expect=2e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=47.8, Expect=2e-06]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} Mlig455_047624 {REF} {Length: 824} {Pfam: WSC domain [PF01822.21, score=55.0]; PAN domain [PF00024.28, score=22.2]; PAN domain [PF14295.8, score=19.1]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=5e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.5, Expect=1e-11]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=4e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} Mlig455_047675 {REF} {Length: 2718} {Pfam: WSC domain [PF01822.21, score=53.8]; PAN domain [PF00024.28, score=21.8]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=6e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=65.5, Expect=4e-12]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=6e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} |
9. | MligTC455_43326 | 39 | 0.8 | Mlig455_057987 | Neo: - Age: - |
2.648 | - | - | 0.952 | 0.741 | 0.955 | - | Mlig455_057987 {REF} {Length: 1058} {RNA1310_129308} | |
10. | MligTC455_30140 | 22 | 0.46 | Mlig455_055220 | Neo: - Age: - |
GALR2 | 2.632 | - | - | 0.963 | 0.781 | 0.888 | - | Mlig455_055220 {REF} {Length: 2272} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=169.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=36.8]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.2]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=21.8]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [RH, Score=167, Expect=4e-47]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [RH, Score=164, Expect=2e-46]} {Dmel: FBgn0036789, AstC-R2, Allatostatin C receptor 2, [RH, Score=133, Expect=8e-34]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=115, Expect=2e-28]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=142, Expect=6e-38]} {RNA1310_26096} |
11. | MligTC455_10786 | 15 | 0.32 | Mlig455_018164 | Neo: - Age: - |
2.627 | - | - | 0.993 | 0.736 | 0.898 | - | Mlig455_018164 {REF} {Length: 1819} {Pfam: F5/8 type C domain [PF00754.27, score=24.0]} {Smed: dd_Smed_v6_15258_0_1, dd_Smed_v6_15258_0_1, [RH, Score=57.8, Expect=5e-10]} {RNA1310_114361} | |
12. | MligTC455_51238 | 58 | 1.21 | Mlig455_011511 | Neo: - Age: - |
KCNMA1 | 2.573 | - | - | 0.816 | 0.807 | 0.950 | - | Mlig455_011511 {REF} {Length: 2300} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=100.8]; Ion channel [PF07885.18, score=29.2]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [Score=272, Expect=4e-80]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [Score=271, Expect=4e-79]} {Dmel: FBgn0003429, slo, slowpoke, [Score=180, Expect=8e-48]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [Score=269, Expect=9e-79]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [Score=294, Expect=9e-88]} {RNA1310_5274} {RNA815_44227} |
13. | MligTC455_44025 | 591 | 12.31 | Mlig455_050980 | Neo: - Age: - Region-specific R2: 5.366 Region-enriched R2: 5.986/0.00000 |
2.567 | - | - | 0.861 | 0.754 | 0.952 | - | Mlig455_050980 {REF} {Length: 587} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=49.7, Expect=7e-09]} {RNA1509_52032} {RNA1310_52449.2} {RNA815_56904} | |
14. | MligTC455_26091 | 161 | 3.36 | Mlig455_047190 | Neo: - Age: - Region-enriched R2: 4.521/0.00020 |
2.557 | - | - | 0.703 | 0.893 | 0.961 | - | Mlig455_047190 {REF} {Length: 2450} {Pfam: Lectin C-type domain [PF00059.23, score=23.6]} {RNA1509_2912} {RNA1310_27113} {RNA815_24719} | |
15. | MligTC455_50844 | 224 | 4.67 | Mlig455_018511 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.591/0.00005 |
SSUH2 | 2.524 | - | - | 0.966 | 0.701 | 0.857 | - | Mlig455_018511 {REF} {Length: 1843} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=120, Expect=2e-29]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=95.5, Expect=3e-21]} {RNA1509_39980} {RNA1310_60742, RNA1509_39980} {RNA1509_39980, RNA815_28938} |
16. | MligTC455_54305 | 43 | 0.89 | Mlig455_035878, Mlig455_035917 | Neo: - Age: - |
ZC3H10 | 2.469 | - | - | 0.773 | 0.743 | 0.953 | - | Mlig455_035878 {REF} {Length: 2474} {tRNA: Val(CAC),pseudo, score=28.9} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=25.6]; CCCH-type zinc finger [PF18044.3, score=20.1]; Zinc-finger containing family [PF15663.7, score=19.3]; Mediator complex subunit 3 fungal [PF11593.10, score=18.0]} {Human: ENSG00000135482, ZC3H10, zinc finger CCCH-type containing 10, [Score=149, Expect=2e-40]} {Mouse: ENSMUSG00000039810, Zc3h10, zinc finger CCCH type containing 10, [Score=149, Expect=2e-40]} {Smed: dd_Smed_v6_7175_0_2, dd_Smed_v6_7175_0_2, [Score=119, Expect=4e-29]} {RNA1509_47157} {RNA1310_87786} {RNA815_46414} Mlig455_035917 {REF} {Length: 2428} {tRNA: Val(CAC),pseudo, score=30.2} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=25.6]; CCCH-type zinc finger [PF18044.3, score=20.1]; Zinc-finger containing family [PF15663.7, score=19.3]; Mediator complex subunit 3 fungal [PF11593.10, score=18.0]} {Human: ENSG00000135482, ZC3H10, zinc finger CCCH-type containing 10, [Score=149, Expect=2e-40]} {Mouse: ENSMUSG00000039810, Zc3h10, zinc finger CCCH type containing 10, [Score=149, Expect=2e-40]} {Smed: dd_Smed_v6_7175_0_2, dd_Smed_v6_7175_0_2, [Score=119, Expect=4e-29]} {RNA1509_47157} {RNA1310_87786} {RNA815_46414} |
17. | MligTC455_37270 | 86 | 1.79 | Mlig455_022293 | Neo: - Age: - |
CASP3 | 2.452 | - | - | 0.951 | 0.779 | 0.722 | - | Mlig455_022293 {REF} {Length: 2773} {Pfam: Caspase domain [PF00656.24, score=93.1]; Ankyrin repeats (3 copies) [PF12796.9, score=77.8]; Ankyrin repeats (many copies) [PF13857.8, score=62.2]; Ankyrin repeats (many copies) [PF13637.8, score=56.0]; Ankyrin repeat [PF13606.8, score=39.1]; Ankyrin repeat [PF00023.32, score=28.2]} {Human: ENSG00000164305, CASP3, caspase 3, [Score=109, Expect=7e-26]; ENSG00000003400, CASP10, caspase 10, [Score=107, Expect=9e-24]; ENSG00000165806, CASP7, caspase 7, [Score=104, Expect=2e-23]} {Mouse: ENSMUSG00000025076, Casp7, caspase 7, [Score=106, Expect=9e-25]; ENSMUSG00000031628, Casp3, caspase 3, [Score=103, Expect=3e-24]} {Dmel: FBgn0010501, Dcp-1, Death caspase-1, [Score=96.3, Expect=3e-21]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=81.6, Expect=9e-17]} {Smed: dd_Smed_v6_3121_1_1, dd_Smed_v6_3121_1_1, [Score=102, Expect=3e-24]} {RNA1509_54818} {RNA1310_7187, RNA1509_54818} {RNA1509_54818, RNA815_8712} |
18. | MligTC455_42044 | 14 | 0.28 | Mlig455_036295 | Neo: - Age: - |
2.41 | - | - | 0.982 | 0.725 | 0.703 | - | Mlig455_036295 {REF} {Length: 1775} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=32.8]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [Score=62.8, Expect=8e-11]} {RNA1310_147392} | |
19. | MligTC455_18384 | 52 | 1.08 | Mlig455_033464, Mlig455_033480 | Neo: - Age: - |
CHRNB3 | 1.984 | - | - | - | 1.000 | 0.984 | - | Mlig455_033464 {REF} {Length: 3273} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=101.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=28.0]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=112, Expect=2e-26]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=107, Expect=4e-25]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=102, Expect=2e-23]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=95.5, Expect=5e-21]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=98.2, Expect=5e-22]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [Score=90.5, Expect=1e-19]} {RNA1509_28510} {RNA1310_44183.1} {RNA815_32188} Mlig455_033480 {REF} {Length: 904} {RNA1310_131495} |
20. | MligTC455_17021 | 49 | 1.02 | Mlig455_030263 | Neo: - Age: - |
1.976 | - | - | 0.979 | - | 0.997 | - | Mlig455_030263 {REF} {Length: 566} {TRANSSPLICED} {Pfam: Galactosyltransferase [PF01762.23, score=23.7]} {Dmel: FBgn0000221, brn, brainiac, [Score=45.8, Expect=1e-06]} {RNA1310_35735} {RNA815_59866} | |
21. | MligTC455_19850 | 21 | 0.44 | Mlig455_016817 | Neo: - |
GUCY1B1 | 1.968 | - | - | 0.978 | - | 0.990 | - | Mlig455_016817 {REF} {Length: 2782} {Pfam: Heme NO binding associated [PF07701.16, score=218.0]; Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=199.9]; Haem-NO-binding [PF07700.17, score=175.1]} {Human: ENSG00000061918, GUCY1B1, guanylate cyclase 1 soluble subunit beta 1, [Score=338, Expect=4e-107]} {Mouse: ENSMUSG00000028005, Gucy1b1, guanylate cyclase 1, soluble, beta 1, [Score=342, Expect=6e-109]; ENSMUSG00000021933, Gucy1b2, guanylate cyclase 1, soluble, beta 2, [Score=339, Expect=1e-105]} {Dmel: FBgn0038295, Gyc88E, Guanylyl cyclase at 88E, [RH, Score=593, Expect=0.0]} {Celegans: WBGene00001551, gcy-31, Soluble guanylate cyclase gcy-31, [RH, Score=513, Expect=2e-174]} {Smed: dd_Smed_v6_18111_0_1, dd_Smed_v6_18111_0_1, [RH, Score=823, Expect=0.0]} {RNA1509_55074} {RNA1310_24262} {RNA815_41754} |
22. | MligTC455_35124 | 780 | 16.25 | Mlig455_059030, Mlig455_070853 | Neo: - Age: Down-Up-Down Region-enriched R6: 6.026/0.00025 |
1.967 | - | - | - | 0.988 | 0.979 | - | Mlig455_059030 {REF} {Length: 944} {Pfam: Dynein light chain type 1 [PF01221.20, score=58.7]; EF-hand domain pair [PF13499.8, score=25.4]; EF hand [PF00036.34, score=21.8]; EF-hand domain [PF14658.8, score=20.5]; EF-hand domain [PF13405.8, score=19.8]} {Smed: dd_Smed_v6_6707_0_3, dd_Smed_v6_6707_0_3, [Score=128, Expect=6e-38]} {RNA1509_37636} {RNA1310_36928, RNA1509_37636} {RNA1509_37636, RNA815_25288} Mlig455_070853 {REF} {Length: 962} {Pfam: Dynein light chain type 1 [PF01221.20, score=58.8]; EF-hand domain pair [PF13499.8, score=25.6]; EF-hand domain [PF13405.8, score=21.1]; EF hand [PF00036.34, score=21.0]; EF-hand domain [PF14658.8, score=20.2]} {Smed: dd_Smed_v6_6707_0_3, dd_Smed_v6_6707_0_3, [Score=127, Expect=7e-38]} {RNA1509_37636} {RNA1310_36928} {RNA815_25288} |
|
23. | MligTC455_10017 | 8 | 0.17 | Mlig455_034677 | Neo: - Age: - |
GUCY2F | 1.966 | - | - | 0.997 | - | 0.969 | - | Mlig455_034677 {REF} {Length: 4582} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.9]; Protein kinase domain [PF00069.27, score=72.7]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=633, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=641, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=708, Expect=0.0]} {RNA1310_64185} |
24. | MligTC455_16844 | 22 | 0.47 | Mlig455_032383 | Neo: - Age: - |
NPY1R | 1.96 | - | - | 0.984 | - | 0.976 | - | Mlig455_032383 {REF} {Length: 1642} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=126.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.7]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=111, Expect=2e-26]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=110, Expect=3e-26]; ENSMUSG00000048337, Npy4r, neuropeptide Y receptor Y4, [Score=108, Expect=1e-25]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=152, Expect=8e-41]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=135, Expect=4e-35]} {Smed: dd_Smed_v6_17752_0_1, dd_Smed_v6_17752_0_1, [Score=216, Expect=3e-65]} {RNA1310_56955} |
25. | MligTC455_17644 | 182 | 3.8 | Mlig455_007930, Mlig455_008033 | Neo: - Age: - |
1.96 | - | - | - | 0.988 | 0.972 | - | Mlig455_007930 {REF} {Length: 2086} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.9]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=3e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} Mlig455_008033 {REF} {Length: 1974} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.6]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=4e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} |
|
26. | MligTC455_21227 | 18 | 0.37 | Mlig455_018373 | Neo: - Age: - |
RGS6 | 1.954 | - | - | 0.977 | - | 0.977 | - | Mlig455_018373 {REF} {Length: 2679} {Pfam: Regulator of G-protein signalling DHEX domain [PF18148.3, score=126.8]; Regulator of G protein signaling domain [PF00615.21, score=113.6]; Domain found in Dishevelled, Egl-10, and Pleckstrin (DEP) [PF00610.23, score=33.8]} {Human: ENSG00000182732, RGS6, regulator of G protein signaling 6, [Score=315, Expect=1e-99]; ENSG00000182901, RGS7, regulator of G protein signaling 7, [Score=310, Expect=5e-98]} {Mouse: ENSMUSG00000021219, Rgs6, regulator of G-protein signaling 6, [Score=310, Expect=1e-97]; ENSMUSG00000026527, Rgs7, regulator of G protein signaling 7, [Score=305, Expect=4e-96]} {Dmel: FBgn0259927, CG42450, [Score=314, Expect=5e-93]} {Celegans: WBGene00001145, eat-16, [RH, Score=242, Expect=3e-72]} {Smed: dd_Smed_v6_5311_0_1, dd_Smed_v6_5311_0_1, [RH, Score=392, Expect=8e-130]} {RNA1310_24067} |
27. | MligTC455_41448 | 192 | 4.01 | Mlig455_066626 | Neo: - Age: - Region-specific R2: 6.449 Region-enriched R2: 4.988/0.02499 |
1.954 | - | - | - | 0.995 | 0.959 | - | Mlig455_066626 {REF} {Length: 987} {Pfam: F5/8 type C domain [PF00754.27, score=25.0]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=52.4, Expect=8e-09]} {RNA1509_36923} {RNA1310_37535} {RNA815_20943} | |
28. | MligTC455_21291 | 27 | 0.57 | Mlig455_009651 | Neo: - Age: - |
1.952 | - | - | 1.000 | - | 0.952 | - | Mlig455_009651 {REF} {Length: 3534} {RNA1310_43941} {RNA815_61115} | |
29. | MligTC455_50931 | 28 | 0.58 | Mlig455_046985, Mlig455_047028 | Neo: - Age: - |
FCN2 | 1.951 | - | - | 0.991 | - | 0.960 | - | Mlig455_046985 {REF} {Length: 3620} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=126.1]; PAN domain [PF14295.8, score=27.4]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=22.7]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=2e-15]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=2e-12]} {Dmel: FBgn0031804, CG9500, [Score=79.0, Expect=1e-15]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=59.7, Expect=6e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881} Mlig455_047028 {REF} {Length: 1979} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=71.8]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=5e-16]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=8e-13]} {Dmel: FBgn0031804, CG9500, [Score=79.3, Expect=3e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=60.5, Expect=1e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881} |
30. | MligTC455_53720 | 144 | 2.99 | Mlig455_028516 | Neo: - Age: - Region-enriched R2: 4.205/0.01762 |
CTBP2 | 1.951 | - | - | 0.970 | - | 0.981 | - | Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484} |
31. | MligTC455_17633 | 25 | 0.51 | Mlig455_066373 | Neo: - Age: - |
RHBG | 1.95 | - | - | 0.988 | - | 0.962 | - | Mlig455_066373 {REF} {Length: 1855} {Pfam: Ammonium Transporter Family [PF00909.23, score=389.0]} {Human: ENSG00000132677, RHBG, Rh family B glycoprotein (gene/pseudogene), [Score=60.8, Expect=3e-09]} {Dmel: FBgn0038309, Amt, Ammonium transporter, [RH, Score=459, Expect=5e-157]} {Celegans: WBGene00000135, amt-3, Putative ammonium transporter 3, [RH, Score=401, Expect=1e-132]} {RNA1310_75971} {RNA815_45087} |
32. | MligTC455_19887 | 43 | 0.9 | Mlig455_012639, Mlig455_012658 | Neo: - Age: - |
AC243734.1 | 1.95 | - | - | 0.994 | - | 0.956 | - | Mlig455_012639 {REF} {Length: 2609} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=222.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=213.5]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=270, Expect=7e-83]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=270, Expect=7e-83]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=267, Expect=1e-81]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=271, Expect=2e-83]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=426, Expect=7e-143]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=317, Expect=8e-101]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=311, Expect=7e-99]} {RNA1509_48029} {RNA1310_34222.1} {RNA815_33884} Mlig455_012658 {REF} {Length: 2365} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=183.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=164.1]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=2e-115]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=2e-115]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=4e-116]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=360, Expect=2e-119]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=409, Expect=5e-138]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=335, Expect=5e-110]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=400, Expect=3e-135]} {RNA1509_48029} {RNA1310_34222.1} {RNA815_33884} |
33. | MligTC455_04855 | 16 | 0.34 | Mlig455_005010, Mlig455_005053, Mlig455_005260 | Neo: - Age: logFC(26M/2M)=0.904 |
HCRTR2 | 1.949 | - | - | 0.999 | - | 0.950 | - | Mlig455_005010 {REF} {Length: 1532} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=207, Expect=5e-61]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=209, Expect=7e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=8e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=4e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=7e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005053 {REF} {Length: 3639} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005260 {REF} {Length: 1614} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} |
34. | MligTC455_15890 | 18 | 0.38 | Mlig455_059636 | Neo: - Age: - |
CD209 | 1.947 | - | - | - | 0.985 | 0.962 | - | Mlig455_059636 {REF} {Length: 1223} {Pfam: Lectin C-type domain [PF00059.23, score=29.7]} {Human: ENSG00000090659, CD209, CD209 molecule, [Score=49.3, Expect=2e-06]} {Dmel: FBgn0040096, lectin-33A, [Score=48.9, Expect=6e-07]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=64.7, Expect=2e-12]} {RNA1509_20946} {RNA1310_53178} {RNA815_42043} |
35. | MligTC455_48713 | 380 | 7.92 | Mlig455_009259, Mlig455_009268 | Neo: - Age: Down-Up-Down Region-specific R2: 6.962 Region-enriched R2: 4.845/0.00046 |
1.947 | - | - | 0.971 | - | 0.976 | - | Mlig455_009259 {REF} {Length: 654} {RNA1509_35038} {RNA1310_72135} {RNA815_37404} Mlig455_009268 {REF} {Length: 546} {RNA1509_35038} {RNA1310_72135, RNA1509_35038} {RNA1509_35038, RNA815_37404} |
|
36. | MligTC455_45285 | 7 | 0.14 | Mlig455_046883 | Neo: - Age: - |
1.946 | - | - | 0.984 | - | 0.962 | - | Mlig455_046883 {REF} {Length: 2303} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=41.2]} {Celegans: WBGene00008885, F16C3.1, [RH, Score=57.0, Expect=2e-08]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=80.5, Expect=3e-16]} {RNA1509_24228} {RNA1310_11273} | |
37. | MligTC455_21801 | 58 | 1.22 | Mlig455_015442, Mlig455_032138 | Neo: - Age: - |
NPY1R | 1.943 | - | - | - | 0.996 | 0.947 | - | Mlig455_015442 {REF} {Length: 2461} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=130.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=26.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.9]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=128, Expect=5e-32]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=122, Expect=2e-30]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=140, Expect=4e-36]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=120, Expect=1e-29]} {Smed: dd_Smed_v6_25204_0_1, dd_Smed_v6_25204_0_1, [Score=208, Expect=2e-61]} {RNA1310_49156} {RNA815_43783} Mlig455_032138 {REF} {Length: 2633} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=129.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.6]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=126, Expect=2e-31]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=122, Expect=4e-30]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=136, Expect=1e-34]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_25934_0_1, dd_Smed_v6_25934_0_1, [Score=207, Expect=5e-61]} {RNA1310_49156} {RNA815_43783} |
38. | MligTC455_42580 | 98 | 2.04 | Mlig455_014929, Mlig455_045199 | Neo: - Age: - |
NKX2-2 | 1.941 | - | - | 0.979 | - | 0.962 | - | Mlig455_014929 {REF} {Length: 1652} {Pfam: Homeodomain [PF00046.31, score=70.3]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=138, Expect=2e-37]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=1e-37]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=4e-35]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=107, Expect=6e-26]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=1e-29]} {RNA1310_42496} {RNA815_52707} Mlig455_045199 {REF} {Length: 1211} {Pfam: Homeodomain [PF00046.31, score=71.0]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=139, Expect=6e-39]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=3e-39]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=1e-36]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=108, Expect=2e-27]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=7e-31]} {RNA1310_42496} {RNA815_52707} |
39. | MligTC455_51334 | 326 | 6.78 | Mlig455_011442, Mlig455_061180 | Neo: - |
1.941 | - | - | 0.959 | - | 0.982 | - | Mlig455_011442 {REF} {Length: 742} {RNA1310_57576.1} {RNA815_29867} Mlig455_061180 {REF} {Length: 769} {RNA1310_57576.1} {RNA815_29867} |
|
40. | MligTC455_33442 | 39 | 0.81 | Mlig455_039767 | Neo: - Age: - |
1.94 | - | - | - | 0.981 | 0.959 | - | Mlig455_039767 {REF} {Length: 1975} {RNA1310_42391} | |
41. | MligTC455_45622 | 647 | 13.48 | Mlig455_069391 | Neo: - Age: - Region-specific R2: 5.132 Region-enriched R2: 3.915/0.00000 Regeneration-downregulated R2: -2.412 Regeneration-depleted R2: -2.412 |
1.939 | - | - | - | 0.995 | 0.944 | - | Mlig455_069391 {REF} {Length: 971} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=45.1, Expect=4e-07]} {RNA1509_31982} {RNA1310_46295} {RNA815_23543} | |
42. | MligTC455_48656 | 24 | 0.5 | Mlig455_039647 | Neo: - Age: - |
1.938 | - | - | 0.999 | - | 0.939 | - | Mlig455_039647 {REF} {Length: 1715} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.7]} {RNA1310_48037} {RNA815_27969} | |
43. | MligTC455_49492 | 10 | 0.21 | Mlig455_054890 | Neo: - Age: - |
1.938 | - | - | 0.976 | - | 0.962 | - | Mlig455_054890 {REF} {Length: 1524} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
44. | MligTC455_10383 | 13 | 0.27 | Mlig455_040199 | Neo: - Age: - |
1.937 | - | - | 0.954 | - | 0.983 | - | Mlig455_040199 {REF} {Length: 860} {Pfam: Lectin C-type domain [PF00059.23, score=27.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
45. | MligTC455_12673 | 10 | 0.2 | Mlig455_003447 | Neo: - Age: - |
1.937 | - | - | 0.996 | - | 0.941 | - | Mlig455_003447 {REF} {Length: 1947} {RNA1509_51609} {RNA1310_3461} {RNA815_16498} | |
46. | MligTC455_43714 | 152 | 3.18 | Mlig455_000684, Mlig455_000736 | Neo: - Age: - |
1.937 | - | - | 0.945 | - | 0.992 | - | Mlig455_000684 {REF} {Length: 796} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} Mlig455_000736 {REF} {Length: 797} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} |
|
47. | MligTC455_48127 | 47 | 0.97 | Mlig455_037173 | Neo: - Age: - |
1.936 | - | - | - | 0.967 | 0.969 | - | Mlig455_037173 {REF} {Length: 1938} {RNA1310_42908} {RNA815_22744} | |
48. | MligTC455_52629 | 472 | 9.83 | Mlig455_059435 | Neo: - Age: Down-Up-Up Region-specific R2: 6.775 Region-enriched R2: 6.727/0.00002 |
1.936 | - | - | 0.980 | - | 0.956 | - | Mlig455_059435 {REF} {Length: 726} {RNA1509_48505} {RNA1310_62885} {RNA815_39881} | |
49. | MligTC455_53233 | 1483 | 30.9 | Mlig455_037746, Mlig455_069921 | Neo: - Age: - Region-specific R2: 7.323 Region-enriched R2: 7.524/0.00000 Regeneration-downregulated R2: -3.635 Regeneration-depleted R2: -3.635 |
PKD2 | 1.935 | - | - | - | 0.987 | 0.948 | - | Mlig455_037746 {REF} {Length: 3024} {Pfam: Polycystin cation channel [PF08016.14, score=468.5]; Ion transport protein [PF00520.33, score=85.9]; EF-hand domain pair [PF13499.8, score=21.3]; EF hand [PF00036.34, score=21.2]; EF-hand domain [PF13405.8, score=18.2]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=708, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=306, Expect=2e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=379, Expect=1e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=719, Expect=0.0]} {RNA1509_30624, RNA1509_6992} {RNA1310_6033, RNA1509_30624} {RNA1509_30624, RNA815_1577.1} Mlig455_069921 {REF} {Length: 3030} {Pfam: Polycystin cation channel [PF08016.14, score=467.0]; Ion transport protein [PF00520.33, score=85.5]; EF hand [PF00036.34, score=21.3]; EF-hand domain pair [PF13499.8, score=21.3]; EF-hand domain [PF13405.8, score=18.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=707, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=304, Expect=8e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=377, Expect=3e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=716, Expect=0.0]} {RNA1509_6992} {RNA1310_6033, RNA1509_6992} {RNA1509_6992, RNA815_1577.1} |
50. | MligTC455_15124 | 25 | 0.53 | Mlig455_017684 | Neo: - Age: - |
IGSF9 | 1.933 | - | - | 0.984 | - | 0.949 | - | Mlig455_017684 {REF} {Length: 3509} {Pfam: Immunoglobulin domain [PF13927.8, score=138.2]; Immunoglobulin I-set domain [PF07679.18, score=105.0]; Immunoglobulin domain [PF13895.8, score=104.0]; Immunoglobulin domain [PF00047.27, score=66.0]; Immunoglobulin V-set domain [PF07686.19, score=56.4]; Fibronectin type III domain [PF00041.23, score=26.9]; Immunoglobulin domain [PF18452.3, score=22.7]; T-cell surface glycoprotein CD3 delta chain [PF16680.7, score=22.1]; Ig-like domain on T-cell surface glycoprotein CD3 epsilon chain [PF16681.7, score=19.2]} {Human: ENSG00000085552, IGSF9, immunoglobulin superfamily member 9, [Score=137, Expect=2e-32]} {Mouse: ENSMUSG00000037995, Igsf9, immunoglobulin superfamily, member 9, [Score=128, Expect=2e-29]; ENSMUSG00000034275, Igsf9b, immunoglobulin superfamily, member 9B, [Score=124, Expect=3e-28]} {Dmel: FBgn0010473, tutl, turtle, [Score=130, Expect=1e-30]} {Celegans: WBGene00020130, igcm-2, ImmunoGlobulin-like Cell adhesion Molecule family, [Score=94.7, Expect=1e-19]} {Smed: dd_Smed_v6_17743_0_1, dd_Smed_v6_17743_0_1, [Score=120, Expect=2e-27]} {RNA1310_85001} |
51. | MligTC455_12183 | 53 | 1.11 | Mlig455_004166, Mlig455_004190 | Neo: - Age: - Region-enriched R2: 4.930/0.01881 |
1.932 | - | - | 0.950 | - | 0.982 | - | Mlig455_004166 {REF} {Length: 2818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.4]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=29.1]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=8e-12]} {RNA1310_64973} {RNA815_58453} Mlig455_004190 {REF} {Length: 2742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=28.6]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=56.2, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=1e-11]} {RNA1310_62602} {RNA815_58453} |
|
52. | MligTC455_29587 | 14 | 0.29 | Mlig455_044070 | Neo: - Age: - |
1.932 | - | - | 0.972 | - | 0.960 | - | Mlig455_044070 {REF} {Length: 1365} {RNA1509_26262} {RNA1310_30838} {RNA815_35621} | |
53. | MligTC455_09405 | 6 | 0.12 | Mlig455_069593 | Neo: - Age: - |
FCN1 | 1.931 | - | - | 0.935 | - | 0.996 | - | Mlig455_069593 {REF} {Length: 1062} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=116.0]} {Human: ENSG00000085265, FCN1, ficolin 1, [Score=111, Expect=5e-28]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=102, Expect=6e-25]; ENSMUSG00000028001, Fga, fibrinogen alpha chain, [Score=100, Expect=4e-23]; ENSMUSG00000026938, Fcna, ficolin A, [Score=100, Expect=4e-24]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=98.6, Expect=1e-22]} {Dmel: FBgn0003326, sca, scabrous, [Score=105, Expect=5e-25]} {Celegans: WBGene00020516, T15B7.1, [Score=62.8, Expect=5e-11]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=44.3, Expect=7e-06]} |
54. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
1.931 | - | - | 0.984 | - | 0.947 | - | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
55. | MligTC455_15949 | 37 | 0.76 | Mlig455_059880 | Neo: - Age: - |
1.93 | - | - | 0.978 | - | 0.952 | - | Mlig455_059880 {REF} {Length: 1226} {Pfam: Lectin C-type domain [PF00059.23, score=39.5]} {Dmel: FBgn0031373, CG15358, [Score=52.8, Expect=4e-08]} {RNA1310_120903} | |
56. | MligTC455_47780 | 214 | 4.46 | Mlig455_018842, Mlig455_018853 | Neo: - Age: - |
1.93 | - | - | 0.992 | - | 0.938 | - | Mlig455_018842 {REF} {Length: 500} {RNA1509_48336} {RNA1310_73351} {RNA815_41082} Mlig455_018853 {REF} {Length: 593} {RNA1509_48336} {RNA1310_73351, RNA1509_48336} {RNA1509_48336, RNA815_41082} |
|
57. | MligTC455_11633 | 28 | 0.58 | Mlig455_025325 | Neo: - Age: - |
NWD2 | 1.928 | - | - | 0.996 | - | 0.932 | - | Mlig455_025325 {REF} {Length: 7673} {Pfam: NACHT domain [PF05729.14, score=32.3]; WD domain, G-beta repeat [PF00400.34, score=28.8]; AAA ATPase domain [PF13191.8, score=26.6]} {Human: ENSG00000174145, NWD2, NACHT and WD repeat domain containing 2, [Score=94.4, Expect=2e-18]} {Mouse: ENSMUSG00000048148, Nwd1, NACHT and WD repeat domain containing 1, [Score=99.4, Expect=4e-20]; ENSMUSG00000090061, Nwd2, NACHT and WD repeat domain containing 2, [Score=95.9, Expect=4e-19]} {Dmel: FBgn0038397, CG10185, [Score=145, Expect=2e-34]} {Celegans: WBGene00020254, T05C3.2, [Score=155, Expect=1e-37]} {Smed: dd_Smed_v6_9023_0_1, dd_Smed_v6_9023_0_1, [Score=221, Expect=8e-58]} {RNA1509_55003} {RNA1310_101755} {RNA815_31021.1} |
58. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
1.928 | - | - | 0.974 | - | 0.954 | - | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
59. | MligTC455_33440 | 62 | 1.29 | Mlig455_053806, Mlig455_053807 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.142/0.02950 |
GRID1 | 1.926 | - | - | 0.956 | - | 0.970 | - | Mlig455_053806 {REF} {Length: 3070} {Pfam: Ligand-gated ion channel [PF00060.28, score=72.9]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.7]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=39.8]; Receptor family ligand binding region [PF01094.30, score=28.6]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=145, Expect=2e-35]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=143, Expect=2e-34]} {Dmel: FBgn0038837, CG3822, [Score=126, Expect=2e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=112, Expect=3e-25]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=257, Expect=1e-77]} {RNA1310_13880.2} {RNA815_12458} Mlig455_053807 {REF} {Length: 3142} {Pfam: Ligand-gated ion channel [PF00060.28, score=79.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=38.3]; Receptor family ligand binding region [PF01094.30, score=36.5]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=139, Expect=2e-33]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=137, Expect=1e-32]} {Dmel: FBgn0038837, CG3822, [Score=125, Expect=5e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=117, Expect=1e-26]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=259, Expect=2e-78]} {RNA1310_13880.2} {RNA815_12458} |
60. | MligTC455_32575 | 62 | 1.29 | Mlig455_024198 | Neo: - Age: logFC(26M/2M)=-0.353 |
FAT4 | 1.925 | - | - | - | 0.969 | 0.956 | - | Mlig455_024198 {REF} {Length: 7971} {Pfam: Cadherin domain [PF00028.19, score=704.5]; Cadherin-like [PF16184.7, score=77.6]; Cadherin-like [PF08266.14, score=39.5]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=501, Expect=3e-142]; ENSG00000107736, CDH23, cadherin related 23, [Score=498, Expect=1e-141]} {Mouse: ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=514, Expect=1e-146]; ENSMUSG00000012819, Cdh23, cadherin 23 (otocadherin), [Score=504, Expect=1e-143]} {Dmel: FBgn0284247, ds, dachsous, [Score=457, Expect=3e-129]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=277, Expect=2e-74]} {Smed: dd_Smed_v6_7638_0_1, dd_Smed_v6_7638_0_1, [Score=276, Expect=8e-74]} {RNA1509_24504} {RNA1310_3168, RNA1509_24504} {RNA1509_24504, RNA815_13217} |
61. | MligTC455_15212 | 12 | 0.26 | Mlig455_059838 | Neo: - Age: - |
ADRA2A | 1.922 | - | - | 0.997 | - | 0.925 | - | Mlig455_059838 {REF} {Length: 2182} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=239.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=36.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=28.6]; Olfactory receptor [PF13853.8, score=28.5]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=200, Expect=2e-57]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=198, Expect=1e-56]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=185, Expect=5e-51]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=195, Expect=5e-56]} {Smed: dd_Smed_v6_19063_0_1, dd_Smed_v6_19063_0_1, [Score=235, Expect=1e-71]} |
62. | MligTC455_11306 | 10 | 0.2 | Mlig455_030223 | Neo: - Age: - |
ANGPT4 | 1.922 | - | - | 0.960 | - | 0.962 | - | Mlig455_030223 {REF} {Length: 1102} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=82.4]} {Human: ENSG00000101280, ANGPT4, angiopoietin 4, [Score=75.5, Expect=4e-15]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=72.8, Expect=2e-14]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=71.6, Expect=6e-14]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=70.5, Expect=1e-13]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=68.9, Expect=6e-13]; ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=68.6, Expect=6e-13]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=68.6, Expect=7e-13]} {Dmel: FBgn0087011, CG41520, [Score=60.8, Expect=2e-10]} {Celegans: WBGene00017013, ensh-1, [Score=46.6, Expect=7e-06]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=61.6, Expect=6e-11]} {RNA1509_28467} {RNA1310_29813.1} {RNA815_57322} |
63. | MligTC455_40791 | 75 | 1.56 | Mlig455_013501 | Neo: - Age: - Region-enriched R2: 7.804/0.01222 |
1.921 | - | - | - | 0.999 | 0.922 | - | Mlig455_013501 {REF} {Length: 2310} {Pfam: WSC domain [PF01822.21, score=57.5]; F5/8 type C domain [PF00754.27, score=52.4]; Clip-domain serine protease homolog Scarface [PF18399.3, score=20.3]} {Smed: dd_Smed_v6_52492_0_1, dd_Smed_v6_52492_0_1, [Score=58.5, Expect=2e-10]} {RNA1509_16751} {RNA1310_14302.1} {RNA815_6113.1} | |
64. | MligTC455_27332 | 6690 | 139.38 | Mlig455_034839, Mlig455_034841, Mlig455_034842 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=0.609 Region-specific R2: 8.988 Region-enriched R2: 9.169/0.00000 Regeneration-depleted R2: -8.701 |
1.921 | - | - | - | 0.966 | 0.955 | - | Mlig455_034839 {REF} {Length: 551} {RNA1509_2874} {RNA1310_102625.1} {RNA815_20834} Mlig455_034841 {REF} {Length: 529} {RNA1509_2874} {RNA1310_102625.1, RNA1509_2874} {RNA1509_2874, RNA815_20834} Mlig455_034842 {REF} {Length: 557} {RNA1509_2874} {RNA1310_102625.1} {RNA815_20834} |
|
65. | MligTC455_10018 | 16 | 0.32 | Mlig455_034726, Mlig455_067577 | Neo: - Age: - |
GUCY2D, GUCY2F | 1.92 | - | - | 0.952 | - | 0.968 | - | Mlig455_034726 {REF} {Length: 4473} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.6]; Protein kinase domain [PF00069.27, score=72.8]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=632, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=640, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=707, Expect=0.0]} {RNA1310_64185} {RNA815_57442} Mlig455_067577 {REF} {Length: 474} {Human: ENSG00000132518, GUCY2D, guanylate cyclase 2D, retinal, [Score=66.2, Expect=9e-13]} {Mouse: ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=65.1, Expect=2e-12]} {Dmel: FBgn0085386, CG34357, [Score=62.0, Expect=1e-11]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [Score=44.7, Expect=9e-06]} {Smed: dd_Smed_v6_39042_0_1, dd_Smed_v6_39042_0_1, [Score=98.2, Expect=2e-25]} {RNA1310_101378} |
66. | MligTC455_23098 | 38 | 0.78 | Mlig455_019169 | Neo: - Age: - Region-enriched R2: 6.693/0.03013 |
NR2E3 | 1.918 | - | - | - | 0.931 | 0.987 | - | Mlig455_019169 {REF} {Length: 2731} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=97.7]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=85.2]} {Human: ENSG00000278570, NR2E3, nuclear receptor subfamily 2 group E member 3, [RH, Score=220, Expect=3e-64]} {Mouse: ENSMUSG00000032292, Nr2e3, nuclear receptor subfamily 2, group E, member 3, [RH, Score=216, Expect=8e-63]} {Dmel: FBgn0034012, Hr51, Hormone receptor 51, [RH, Score=189, Expect=2e-51]} {Celegans: WBGene00001400, fax-1, Nuclear hormone receptor FAX-1, [RH, Score=179, Expect=1e-49]} {Smed: dd_Smed_v6_24412_0_1, dd_Smed_v6_24412_0_1, [RH, Score=196, Expect=3e-54]} {RNA1310_101745} |
67. | MligTC455_53741 | 27 | 0.57 | Mlig455_014136 | Neo: - Age: - |
POMGNT1 | 1.918 | - | - | 1.000 | - | 0.918 | - | Mlig455_014136 {REF} {Length: 2328} {Pfam: GNT-I family [PF03071.17, score=64.4]} {Human: ENSG00000085998, POMGNT1, protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-), [RH, Score=212, Expect=3e-59]} {Mouse: ENSMUSG00000028700, Pomgnt1, protein O-linked mannose beta 1,2-N-acetylglucosaminyltransferase, [RH, Score=211, Expect=2e-59]} {Dmel: FBgn0034521, Mgat1, Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 1, [Score=65.5, Expect=6e-11]} {Celegans: WBGene00001639, gly-14, GLYcosylation related; UDP-N-acetylglucosamine:a-3-D-mannoside b-1,2-N-acetylglucosaminyltransferase I, [Score=60.5, Expect=2e-09]} {Smed: dd_Smed_v6_17617_0_1, dd_Smed_v6_17617_0_1, [RH, Score=179, Expect=1e-48]} {RNA1310_40753} {RNA815_46657} |
68. | MligTC455_53838 | 10 | 0.21 | Mlig455_008156 | Neo: - Age: - |
1.918 | - | - | 0.956 | - | 0.962 | - | Mlig455_008156 {REF} {Length: 2378} {Smed: dd_Smed_v6_4245_0_1, dd_Smed_v6_4245_0_1, [Score=54.7, Expect=7e-08]} {RNA1310_37888} {RNA815_29107} | |
69. | MligTC455_36698 | 41 | 0.85 | Mlig455_020379, Mlig455_020438 | Neo: - Age: - Region-enriched R4: 4.050/0.03458 |
1.916 | - | - | 0.981 | - | 0.935 | - | Mlig455_020379 {REF} {Length: 1748} {Celegans: WBGene00007723, C25F9.2, [Score=77.8, Expect=7e-17]} {RNA1509_21495} {RNA1310_13315} {RNA815_8935} Mlig455_020438 {REF} {Length: 2872} {Pfam: DNA polymerase type B, organellar and viral [PF03175.15, score=53.1]} {Celegans: WBGene00007723, C25F9.2, [Score=206, Expect=7e-57]} {RNA1509_21495} {RNA1310_13315} {RNA815_8935} |
|
70. | MligTC455_24244 | 290 | 6.04 | Mlig455_062623, Mlig455_067528, Mlig455_070336 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.603/0.00020 |
1.915 | - | - | - | 0.984 | 0.931 | - | Mlig455_062623 {REF} {Length: 1154} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=68.1]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=71.6, Expect=3e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_067528 {REF} {Length: 1190} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.0]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=72.4, Expect=1e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_070336 {REF} {Length: 859} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.7]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [Score=57.4, Expect=1e-10]} {RNA1310_40891} {RNA815_16565} |
|
71. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
1.914 | - | - | 0.948 | - | 0.966 | - | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
72. | MligTC455_29100 | 53 | 1.11 | Mlig455_022386, Mlig455_022475 | Neo: - Age: - Region-enriched R2: 7.567/0.00114 |
KREMEN2 | 1.913 | - | - | 0.979 | - | 0.934 | - | Mlig455_022386 {REF} {Length: 4145} {tRNA: Val(CAC),pseudo, score=29.3} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=48.5, Expect=3e-06]; ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=47.0, Expect=7e-06]} {RNA1509_55375} {RNA1310_18706} {RNA815_23500} Mlig455_022475 {REF} {Length: 3047} {Pfam: WSC domain [PF01822.21, score=46.0]; PAN domain [PF00024.28, score=23.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=51.2, Expect=4e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=53.5, Expect=5e-08]} {RNA1509_47157} {RNA1310_35396.1} {RNA815_23500} |
73. | MligTC455_45621 | 610 | 12.72 | Mlig455_041531 | Neo: - Age: - Region-specific R2: 5.645 Region-enriched R2: 4.169/0.00001 |
1.913 | - | - | - | 0.986 | 0.927 | - | Mlig455_041531 {REF} {Length: 1004} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=45.1, Expect=4e-07]} {RNA1509_31982, RNA1509_8166} {RNA1310_46295, RNA1509_31982, RNA1509_8166} {RNA1509_31982, RNA1509_8166, RNA815_23543} | |
74. | MligTC455_48720 | 1367 | 28.48 | Mlig455_017034 | Neo: - Age: - Region-specific R2: 4.593 Region-enriched R2: 3.164/0.00157 |
1.913 | - | - | - | 0.992 | 0.921 | - | Mlig455_017034 {REF} {Length: 866} {RNA1509_17554, RNA1509_28146} {RNA1310_40772, RNA1509_28146} {RNA1509_28146, RNA815_29897} | |
75. | MligTC455_40388 | 23 | 0.47 | Mlig455_019615 | Neo: - Age: - |
1.913 | - | - | 0.952 | - | 0.961 | - | Mlig455_019615 {REF} {Length: 2102} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=34.2]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=144, Expect=9e-37]} {RNA1310_29891} {RNA815_15562} | |
76. | MligTC455_18945 | 41 | 0.86 | Mlig455_031602 | Neo: - Age: - |
1.912 | - | - | 0.973 | - | 0.939 | - | Mlig455_031602 {REF} {Length: 914} {RNA1310_75361} {RNA815_24378} | |
77. | MligTC455_32554 | 51 | 1.07 | Mlig455_024179 | Neo: - Age: - |
1.912 | - | - | - | 0.954 | 0.958 | - | Mlig455_024179 {REF} {Length: 926} {RNA1509_24504} {RNA1310_3168} {RNA815_18309} | |
78. | MligTC455_40340 | 201 | 4.19 | Mlig455_021026, Mlig455_021062 | Neo: - Age: - |
1.912 | - | - | 0.967 | - | 0.945 | - | Mlig455_021026 {REF} {Length: 1609} {RNA1310_21018} {RNA815_22069} Mlig455_021062 {REF} {Length: 1582} {RNA1310_21018} {RNA815_22069} |
|
79. | MligTC455_42256 | 163 | 3.39 | Mlig455_054046 | Neo: - Age: Down-Up-Up |
LDB2 | 1.912 | - | - | 0.944 | - | 0.968 | - | Mlig455_054046 {REF} {Length: 2089} {Pfam: LIM-domain binding protein [PF01803.18, score=164.3]; LIM interaction domain (LID) [PF17916.3, score=55.5]} {Human: ENSG00000169744, LDB2, LIM domain binding 2, [RH, Score=390, Expect=4e-132]} {Mouse: ENSMUSG00000039706, Ldb2, LIM domain binding 2, [RH, Score=388, Expect=3e-131]} {Dmel: FBgn0013764, Chi, Chip, [RH, Score=332, Expect=9e-107]} {Celegans: WBGene00002261, ldb-1, F58A3.1a; LIM Domain Binding protein, [RH, Score=155, Expect=2e-40]} {Smed: dd_Smed_v6_3678_0_1, dd_Smed_v6_3678_0_1, [Score=321, Expect=1e-102]} {RNA1310_27326} {RNA815_22302} |
80. | MligTC455_46462 | 7 | 0.15 | Mlig455_025120 | Neo: - Age: - |
1.912 | - | - | 0.998 | - | 0.914 | - | Mlig455_025120 {REF} {Length: 1291} | |
81. | MligTC455_17175 | 78 | 1.62 | Mlig455_042330, Mlig455_047110 | Neo: - Age: - |
GABRA6 | 1.911 | - | - | - | 0.923 | 0.988 | - | Mlig455_042330 {REF} {Length: 1845} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=104.1]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [Score=236, Expect=1e-72]; ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [Score=229, Expect=4e-69]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [Score=241, Expect=9e-75]} {Dmel: FBgn0030707, CG8916, [Score=248, Expect=4e-77]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [Score=227, Expect=2e-69]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=242, Expect=6e-76]} {RNA1310_60750} {RNA815_41846} Mlig455_047110 {REF} {Length: 1843} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=138.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.4]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [Score=248, Expect=4e-76]; ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [Score=246, Expect=4e-74]; ENSG00000151834, GABRA2, gamma-aminobutyric acid type A receptor alpha2 subunit, [Score=243, Expect=4e-74]; ENSG00000186297, GABRA5, gamma-aminobutyric acid type A receptor alpha5 subunit, [Score=242, Expect=1e-73]; ENSG00000011677, GABRA3, gamma-aminobutyric acid type A receptor alpha3 subunit, [Score=239, Expect=3e-72]; ENSG00000022355, GABRA1, gamma-aminobutyric acid type A receptor alpha1 subunit, [Score=239, Expect=2e-72]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=236, Expect=2e-71]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [Score=254, Expect=1e-78]; ENSMUSG00000029211, Gabra4, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 4, [Score=244, Expect=1e-73]; ENSMUSG00000055078, Gabra5, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5, [Score=244, Expect=1e-74]; ENSMUSG00000000560, Gabra2, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2, [Score=243, Expect=4e-74]} {Dmel: FBgn0030707, CG8916, [Score=268, Expect=2e-83]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [Score=252, Expect=1e-77]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=263, Expect=1e-82]} {RNA1310_60750} {RNA815_41846} |
82. | MligTC455_20088 | 39 | 0.81 | Mlig455_017821 | Neo: - Age: Up-Down-Down |
GLIPR1 | 1.908 | - | - | - | 0.978 | 0.930 | - | Mlig455_017821 {REF} {Length: 2083} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=62.2]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [Score=89.4, Expect=2e-19]} {Mouse: ENSMUSG00000025431, Crisp1, cysteine-rich secretory protein 1, [RH, Score=84.3, Expect=5e-18]} {Dmel: FBgn0038126, CG8483, [Score=54.3, Expect=1e-07]} {Celegans: WBGene00003055, lon-1, LONg, [Score=78.6, Expect=5e-16]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=143, Expect=7e-37]} {RNA1310_43937.1} {RNA815_38891} |
83. | MligTC455_37372 | 24 | 0.5 | Mlig455_068455 | Neo: - Age: - |
1.908 | - | - | 1.000 | - | 0.908 | - | Mlig455_068455 {REF} {Length: 2670} {RNA1310_9941.1} {RNA815_16538} | |
84. | MligTC455_39531 | 19 | 0.4 | Mlig455_057918, Mlig455_057946 | Neo: - Age: - |
1.908 | - | - | 0.912 | - | 0.996 | - | Mlig455_057918 {REF} {Length: 2991} {TRANSSPLICED} {Pfam: Ammonium Transporter Family [PF00909.23, score=377.5]} {Dmel: FBgn0038309, Amt, Ammonium transporter, [Score=172, Expect=3e-47]} {Celegans: WBGene00000133, amt-1, Putative ammonium transporter 1, [RH, Score=436, Expect=1e-148]} {RNA1509_13635} {RNA1310_87070} {RNA815_45884} Mlig455_057946 {REF} {Length: 2075} {Pfam: Ammonium Transporter Family [PF00909.23, score=379.7]} {Dmel: FBgn0038309, Amt, Ammonium transporter, [Score=171, Expect=2e-46]} {Celegans: WBGene00000133, amt-1, Putative ammonium transporter 1, [RH, Score=434, Expect=8e-148]} {RNA1310_87070} {RNA815_45884} |
|
85. | MligTC455_49434 | 157 | 3.26 | Mlig455_068252, Mlig455_068272 | Neo: - Age: - |
1.908 | - | - | 0.951 | - | 0.957 | - | Mlig455_068252 {REF} {Length: 718} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.5, Expect=1e-12]} {RNA1310_75052} Mlig455_068272 {REF} {Length: 1055} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.2, Expect=2e-12]} {RNA1310_75052} |
|
86. | MligTC455_50794 | 32 | 0.67 | Mlig455_026944, Mlig455_027032, Mlig455_027095 | Neo: - Age: - |
1.908 | - | - | 0.973 | - | 0.935 | - | Mlig455_026944 {REF} {Length: 1102} {Pfam: Lectin C-type domain [PF00059.23, score=41.7]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [RH, Score=73.2, Expect=1e-15]} {RNA1310_33496.1} {RNA815_23317} Mlig455_027032 {REF} {Length: 1107} {Pfam: Lectin C-type domain [PF00059.23, score=45.3]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [RH, Score=72.4, Expect=3e-15]} {RNA1310_33496.1} {RNA815_23317} Mlig455_027095 {REF} {Length: 1081} {Pfam: Lectin C-type domain [PF00059.23, score=43.8]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=66.6, Expect=4e-13]} {RNA1310_33496.1} {RNA815_23317} |
|
87. | MligTC455_26004 | 161 | 3.34 | Mlig455_005523, Mlig455_036228 | Neo: - Age: logFC(26M/2M)=0.483 Region-enriched R2: 3.880/0.02863 |
1.907 | - | - | - | 0.922 | 0.985 | - | Mlig455_005523 {REF} {Length: 3106} {RNA1509_54312} {RNA1310_125315} {RNA815_31978} Mlig455_036228 {REF} {Length: 3817} {RNA1509_54312} {RNA1310_75243} {RNA815_31978} |
|
88. | MligTC455_12511 | 68 | 1.42 | Mlig455_017662 | Neo: - Age: - |
1.906 | - | - | 0.946 | - | 0.960 | - | Mlig455_017662 {REF} {Length: 906} {RNA1310_37507} {RNA815_32171} | |
89. | MligTC455_19454 | 11 | 0.23 | Mlig455_034200 | Neo: - Age: - |
KREMEN1 | 1.906 | - | - | 0.948 | - | 0.958 | - | Mlig455_034200 {REF} {Length: 1253} {Pfam: WSC domain [PF01822.21, score=46.0]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=55.5, Expect=6e-08]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=57.8, Expect=6e-09]} {RNA1310_36702.1} {RNA815_33128} |
90. | MligTC455_43979 | 188 | 3.92 | Mlig455_000082, Mlig455_063749 | Neo: - Age: - |
GHSR | 1.906 | - | - | 0.947 | - | 0.959 | - | Mlig455_000082 {REF} {Length: 1342} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=53.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.2]} {Human: ENSG00000121853, GHSR, growth hormone secretagogue receptor, [Score=52.0, Expect=7e-07]} {Mouse: ENSMUSG00000051136, Ghsr, growth hormone secretagogue receptor, [Score=50.4, Expect=2e-06]} {Celegans: WBGene00018798, gnrr-1, GoNadotropin-Releasing hormone Receptor (GnRHR) related, [Score=48.9, Expect=3e-06]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=160, Expect=9e-47]} {RNA1310_30553} Mlig455_063749 {REF} {Length: 1323} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=48.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.4]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=157, Expect=1e-45]} {RNA1310_30553} |
91. | MligTC455_14842 | 21 | 0.45 | Mlig455_041074 | Neo: - Age: - |
1.905 | - | - | 0.988 | - | 0.917 | - | Mlig455_041074 {REF} {Length: 1383} {RNA1310_60383} {RNA815_48502} | |
92. | MligTC455_34518 | 327 | 6.81 | Mlig455_049366, Mlig455_062300 | Neo: - Age: - Region-enriched R2: 6.673/0.00158 |
DMRTA2 | 1.905 | - | - | - | 0.958 | 0.947 | - | Mlig455_049366 {REF} {Length: 1964} {Pfam: DM DNA binding domain [PF00751.20, score=82.7]; DMRTA motif [PF03474.16, score=39.9]} {Human: ENSG00000142700, DMRTA2, DMRT like family A2, [RH, Score=155, Expect=4e-41]} {Mouse: ENSMUSG00000047143, Dmrta2, doublesex and mab-3 related transcription factor like family A2, [RH, Score=154, Expect=1e-40]} {Dmel: FBgn0039683, dmrt99B, doublesex-Mab related 99B, [RH, Score=159, Expect=1e-42]} {Celegans: WBGene00017326, dmd-5, DM (Doublesex/MAB-3) Domain family, [RH, Score=139, Expect=7e-38]} {Smed: dd_Smed_v6_31674_0_1, dd_Smed_v6_31674_0_1, [RH, Score=137, Expect=9e-38]} {RNA1310_36206} {RNA815_36280} Mlig455_062300 {REF} {Length: 2056} {Pfam: DM DNA binding domain [PF00751.20, score=82.7]; DMRTA motif [PF03474.16, score=39.9]} {Human: ENSG00000142700, DMRTA2, DMRT like family A2, [RH, Score=155, Expect=4e-41]} {Mouse: ENSMUSG00000047143, Dmrta2, doublesex and mab-3 related transcription factor like family A2, [RH, Score=154, Expect=1e-40]} {Dmel: FBgn0039683, dmrt99B, doublesex-Mab related 99B, [RH, Score=159, Expect=1e-42]} {Celegans: WBGene00017326, dmd-5, DM (Doublesex/MAB-3) Domain family, [RH, Score=139, Expect=8e-38]} {Smed: dd_Smed_v6_31674_0_1, dd_Smed_v6_31674_0_1, [RH, Score=137, Expect=8e-38]} {RNA1310_36206} {RNA815_36280} |
93. | MligTC455_19552 | 288 | 6 | Mlig455_055936, Mlig455_068188 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.424 Region-specific R2: 6.302 Region-enriched R2: 4.919/0.00633 Regeneration-depleted R4: -5.607 |
1.903 | - | - | 0.946 | - | 0.957 | - | Mlig455_055936 {REF} {Length: 665} {RNA1310_71052} {RNA815_36745} Mlig455_068188 {REF} {Length: 714} {RNA1310_71052} {RNA815_36745} |
|
94. | MligTC455_23314 | 139 | 2.9 | Mlig455_039680 | Neo: - Age: - |
CACNA2D2 | 1.903 | - | - | 0.960 | - | 0.943 | - | Mlig455_039680 {REF} {Length: 4498} {Pfam: VWA N-terminal [PF08399.13, score=89.9]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=86.3]; von Willebrand factor type A domain [PF13768.8, score=38.0]; von Willebrand factor type A domain [PF00092.30, score=36.1]; von Willebrand factor type A domain [PF13519.8, score=31.5]; Cache domain [PF02743.20, score=26.9]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [RH, Score=340, Expect=6e-98]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=328, Expect=3e-94]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [RH, Score=338, Expect=1e-97]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=330, Expect=4e-95]} {Dmel: FBgn0028863, CG4587, [RH, Score=234, Expect=2e-62]} {Celegans: WBGene00007041, tag-180, [RH, Score=169, Expect=3e-42]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=155, Expect=5e-38]} {RNA1509_48733} {RNA1310_3844, RNA1509_48733} {RNA1509_48733, RNA815_18071} |
95. | MligTC455_45123 | 17 | 0.35 | Mlig455_003259, Mlig455_062838 | Neo: - Age: - |
1.902 | - | - | 0.997 | - | 0.905 | - | Mlig455_003259 {REF} {Length: 988} {Pfam: WSC domain [PF01822.21, score=59.6]; PAN domain [PF00024.28, score=21.3]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=61.2, Expect=1e-10]} {RNA1509_42596} {RNA1310_44497} {RNA815_21593} Mlig455_062838 {REF} {Length: 844} {Pfam: PAN domain [PF00024.28, score=27.6]} {RNA1509_39816} {RNA1310_44497} {RNA815_21593} |
|
96. | MligTC455_29412 | 46 | 0.96 | Mlig455_000627, Mlig455_008268, Mlig455_040614 | Neo: - Age: Up-Down-Up |
1.901 | - | - | 0.987 | - | 0.914 | - | Mlig455_000627 {REF} {Length: 1331} {RNA1310_62571} {RNA815_30942} Mlig455_008268 {REF} {Length: 1779} {RNA1509_47298} {RNA1310_98344} {RNA815_10804.1} Mlig455_040614 {REF} {Length: 1016} |
|
97. | MligTC455_19304 | 36 | 0.76 | Mlig455_036451 | Neo: - Age: - |
1.901 | - | - | 0.956 | 0.945 | - | - | Mlig455_036451 {REF} {Length: 1603} {Smed: dd_Smed_v6_16261_0_1, dd_Smed_v6_16261_0_1, [RH, Score=266, Expect=8e-87]} {RNA1310_117429} | |
98. | MligTC455_23100 | 527 | 10.99 | Mlig455_019660 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.306 Region-enriched R2: 3.360/0.00019 |
1.9 | - | - | - | 0.989 | 0.911 | - | Mlig455_019660 {REF} {Length: 2113} {RNA1509_29678} {RNA1310_49452, RNA1509_29678} {RNA1509_29678, RNA815_4585} | |
99. | MligTC455_27785 | 115 | 2.39 | Mlig455_001141 | Neo: - |
HMCN2 | 1.9 | - | - | - | 0.952 | 0.948 | - | Mlig455_001141 {REF} {Length: 2156} {Pfam: von Willebrand factor type A domain [PF13519.8, score=54.7]; von Willebrand factor type A domain [PF13768.8, score=30.6]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=81.3, Expect=2e-15]} {Mouse: ENSMUSG00000007030, Vwa7, von Willebrand factor A domain containing 7, [Score=79.0, Expect=6e-15]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=77.8, Expect=2e-14]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=96.3, Expect=1e-20]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=79.7, Expect=2e-15]} {RNA1509_38050} {RNA1310_19586} {RNA815_17693} |
100. | MligTC455_46699 | 33 | 0.69 | Mlig455_037050 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.785 Region-enriched R4: 3.253/0.03515 |
1.9 | - | - | 0.948 | - | 0.952 | - | Mlig455_037050 {REF} {Length: 1266} {Pfam: WD repeat binding protein EZH2 [PF11616.10, score=36.8]; NOPS (NUC059) domain [PF08075.13, score=32.2]; YtkA-like [PF13115.8, score=19.1]} {RNA1509_45891} {RNA1310_92759} {RNA815_24028} |